DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 Print  Email    

Amarin Corporation PLC (AMRN) Announces Pricing of $150 Million of Exchangeable Senior Notes Due 2032


1/4/2012 9:31:29 AM

BEDMINSTER, N.J. and DUBLIN, Ireland, Jan. 4, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN) announced today that its wholly owned subsidiary, Corsicanto Limited, a private limited company incorporated under the laws of Ireland (the "Issuer"), priced its previously announced offering of $150 million in aggregate principal amount of exchangeable senior notes due 2032 (the "notes") to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended. The transaction, which is subject to customary closing conditions, is expected to close on January 9, 2012. The initial purchasers of the notes will have a 30-day option to purchase up to $22.5 million in aggregate principal amount of the notes solely to cover over-allotments, if any.

Read at GlobeNewswire

 Read Article at  Related Companies  News Categories
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 
    

//-->